May 07, 2020
Sosei Heptares Announces Further Scientific Progress with Orexin Agonist Program in Conjunction With Spin-off Companies Orexia and Inexia
Feb 13, 2020
Isotopia Molecular Imaging and Eckert & Ziegler to Start Partnership for Prostate Cancer Imaging
Jan 13, 2020
Sosei Heptares: Significant Progress by Orexia and Inexia With Orexin Agonist Program Triggers Next Tranche of Funding From Medicxi
Oct 09, 2019
GE Healthcare and Theragnostics Announce Global Commercial Partnership for Late Stage PSMA Diagnostic for Prostate Cancer
Sep 13, 2019
Eisai And Biogen To Discontinue Phase III Clinical Studies Of BACE Inhibitor Elenbecestat In Early Alzheimer's Disease
Jul 18, 2019
BioArctic and Eisai Present New Data Regarding BAN2401 at the Alzheimer's Association International Conference 2019
Jul 09, 2019
Applied BioMath, LLC to Present at Alzheimer's Association International Conference®
May 10, 2019
BioArctic: Alzheimer's Clinical Trials Consortium and Eisai Announce BAN2401 to be Evaluated in Clinical Study for Prevention of Alzheimer's Disease
May 10, 2019
Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401 for Upcoming Clinical Studies on Prevention of Alzheimer's Disease
Mar 21, 2019
Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer's Disease
Feb 05, 2019
McCord Research Identifies Olive Compounds that May Act Against Alzheimer's Disease
Jan 31, 2019
Selectivity for the Toxic Oligomer Essential to Treating Root Cause of Alzheimer's Disease
Jan 17, 2019
ProMIS Neurosciences to Participate in NobleCon15 and CanTech Investment Conferences
Dec 18, 2018
ProMIS Neurosciences to Present at Sachs Associates Neuroscience Innovation Forum and China Focus@JPMWeek
Nov 13, 2018
ProMIS Neurosciences Announces Third Quarter 2018 Results
Nov 06, 2018
ProMIS Neurosciences Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer's Disease
Jul 25, 2018
Eisai And Biogen Announce Detailed Results Of Phase II Clinical Study Of BAN2401 In Early Alzheimer's Disease At Alzheimer's Association International Conference (AAIC) 2018
Jul 18, 2018
Eisai To Present Latest Data On Alzheimer's Disease / Dementia Pipeline At Alzheimer's Association International Conference 2018
Jul 10, 2018
ProMIS Neurosciences to Present Preclinical Data on Alzheimer's Disease Therapeutic Antibody PMN310 at Alzheimer's Association International Conference
May 17, 2018
Aptinyx Appoints Robert Hombach to Board of Directors